Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
Only healthy participants will be enrolled in Cohorts 1 through 6. Only participants with early PD will be enrolled in Cohort 7
Age
40–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. All women of childbearing potential and all men must practice effective contraception during the study and for 6 months after their last dose of study treatment.
2. Must have a body mass index from 19 to 32 kg/m2, inclusive.
3. Must be in good health as determined by the Investigator, based on medical history, physical examination, and 12-lead ECG.
For cohort 7 only:
4. Diagnosis of idiopathic PD
You may not be if
1. History of cardiovascular disease.
2. Subject smokes more than 5 cigarettes or the equivalent in tobacco daily.
3. Surgery within 3 months prior to Day -1 (other than minor cosmetic surgery and minor dental surgery, as determined by the Investigator).
4. History or positive test result for hepatitis C, hepatitis B, or human immunodeficiency virus (HIV).
5. Female subjects who are pregnant, currently breastfeeding, or attempting to conceive during the study.
Clareo Health | Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
